Avitas Wealth Management LLC Intellia Therapeutics, Inc. Transaction History

Avitas Wealth Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 28, 2022	SELL	$58.27 - $118.99 $488,943 - $998,445	-8,391 Closed	0 $0
Q4 2021 Jan 26, 2022	BUY	$100.76 - $138.36 $45,140 - $61,985	448 Added 5.64%	8,391 $992,000
Q3 2021 Oct 28, 2021	SELL	$132.37 - $176.78 $1,058 - $1,414	-8 Reduced 0.1%	7,943 $1.07 Million
Q2 2021 Jul 12, 2021	SELL	$60.88 - $161.91 $160,784 - $427,604	-2,641 Reduced 24.93%	7,951 $1.29 Million
Q1 2021 May 13, 2021	SELL	$46.59 - $83.68 $351,055 - $630,528	-7,535 Reduced 41.57%	10,592 $850,000
Q4 2020 Feb 26, 2021	BUY	$18.83 - $63.53 $341,331 - $1.15 Million	18,127 New	18,127 $986,000

324

91.5M

442K

880K

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $744M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

Get notified when there are updates to the investment portfolio of Avitas Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Avitas Wealth Management LLC with notifications on news.